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INTRODUCTION 
  Diabetes Mellitus is a disease with neurovascular and 
metabolic elements. These elements are related to each other. 
Changes in the metabolism of carbohydrate, proteins and lipids are 
secondary to absent or decreased secretion of insulin or due to 
ineffective action of insulin. Vascular syndrome is due to 
abnormalities in small vessels (microangiopathy).Neuropathic 
changes occur in peripheral nervous system due to metabolic and 
vascular causes.  
About 366 million persons were affected by Diabetes Mellitus 
in the year 2011 and this will increase to about 552 million by the 
year 20301.One of the most common cause of hospitalization in 
diabetics is due to foot infections. Foot lesions develop in 25% of 
this group during their period of life2. One of the largest diabetic 
populations in the world is currently in India. Overall incidence of 
diabetes in India is 1.2 %3 of which incidence in urban population 
is 4 to 11% and incidence in rural population is 2.4%4.Diabetes 
Mellitus Prevalence increases after the age of 40 years,15 to 20% 
increase after the age of 65 years.  
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Diabetics battle numerous complications related to their 
underlying disease but none is more devastating both 
psychologically and economically than gangrene of extremity with 
associated risk of amputation. Diabetic peripheral polyneuropathy 
is the major cause of diabetic foot wounds. In patients with 
neuropathy non healing ulcers precede to 80% of amputation. The 
risk of amputation increases by eight times in patients with diabetes 
of age more than 45 years and twelve times more in patients aged 
above 65 years 3,4.If an amputation is done in one limb, the 
incidence of second amputation in contralateral limb is about 50% 
in 2 years. In India most of the people are barefoot walkers. 
Without knowing that they have lost sensation and protective 
reflexes, they walk and have repeated trauma and foot gets infected. 
These groups have to be counseled regularly to prevent the 
recurrence of the wounds on the foot. Charcot’s deformity of the 
joints of the foot occurs in 2.5% of the diabetic population. 
 The reconstruction of diabetic foot after the revascularisation 
is a challenge. To do this a complete knowledge of the vascular 
anatomy, disease pathology, nature of rehabilitation and 
reconstructive procedures is necessary. Functional reconstruction 
means to reconstruct the mechanical design to bear weight. This 
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includes reconstruction of skin to the bones of the foot. The 
decreased vascularity of the foot should be recognized first as this 
delays the normal healing of the wound. Next step is 
revascularization and establishment of wound healing 
potential.Revascularisation is done by endovascular or surgical 
techniques. The first option is endovascular. Regional Vascular 
deficiency following revascularization is corrected and then the 
functional reconstruction is carried out. Regional Vascular 
Insufficiency is  failure of wound healing due to perfusion 
deficiency attributed to diabetic functional micro angiopathy in the 
presence of good macro vascular blood flow after revascularization. 
 Limb loss makes the life difficult for Indian people by 
reducing their income. The cost of health care and burden over the 
families of diabetic foot patients is huge therefore it is necessary to 
study the methods of foot salvage by reconstruction procedures 
instead of amputation. 
 
 
 
 
 
  4
REVIEW OF LITERATURE 
HISTORY OF DIABETES MELLITUS 
 History of Diabetes can be divided into four periods5. 
1. Ancient period 
2. Diagnostic period 
3. Empirical treatment period 
4. Modern period 
1. ANCIENT PERIOD (UPTO 1675 AD)6 
An Egyptian Papyrus (1500 BC), was discovered at Luxor in 
Egypt in the year 1872 by George Ebees.This journal has record the 
symptoms of passing frequent and large quantity of urine.Diabetes 
was understood in ancient India.  Charaka(300 BC) in his charaka 
samhita mentioned about the sweetness of urine in addition to the 
symptom of polyuria.Sushruta in 500 BC described Diabetes as 
“Madhu Meha” – Honey urine. He also described the symptoms of 
polyphagia,polydipsia and polyuria. They noted that this disease 
was prevalent in people who were indolent, overweight and 
gluttons. 
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Chen Chen in 7 th century described as sugary urine. The first 
description of diabetic gangrene was given by Avicenna 
(980 – 1037),an Arabian physician. He described the condition as 
sugary urine and causing impotence and gangrene.Aretaecus of 
Cappodocia(2 AD) gave description of the disease as melting down 
of flesh and limbs into urine.Aretaeus described the term 
“Diabetes”  means siphon in Greek. This disease causes fluid to go 
out of the body and uses the body like a channel to exit. 
2. DIAGNOSTIC PERIOD (1675 – 1796) 
Thomas Willis in the year 1675 AD described that the urine of 
a diabetic patient was wonderfully sweet.Mortan in the year 1678 
AD described the hereditary nature of Diabetes.Mathew Dobson in 
the year 1784 proved that sweetness of urine is due to 
sugar.Thomas Cawly in the year 1778 described in fatal cases of 
Diabetes had abnormal changes in pancreas.Cullen (1709 – 1790) 
added the adjective “Mellitus” to the disease to distinguish it from 
Diabetes Insipidus .Sugar from urine was isolated by adding yeast 
to urine by Francis. 
3. EMPIRICAL TREATMENT PERIOD (1796 – 1850 AD) 
In the year 1796 Rollo advised a diet which was restricted to 
low food value foods of green vegetables and animal fat. Little 
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bread and milk was permitted occasionally. This was done to 
combat diabetes. Smell of acetone in the breath of young diabetic 
patients was noticed by Kussmaul.In the year 1850 Michel Eugene 
Chevreul showed that the sugar in diabetics urine is glucose. 
4. MODERN PERIOD (1850 ONWARDS) 
M.Gregor in this period demonstrated fermentable substance 
in diabetic patients.Qualitative test for sugar in the urine of 
diabetics was described by Trammer.Acetone was discovered in the 
urine of diabetic coma patients by Peter in the year 1857 AD.All 
diabetics are due to pancreatic abnormality was Baumel’s 
hypothesis.Bouchardet (1806 – 1886) advised the daily testing of 
urine for sugar. The features of diabetes mellitus was demonstrated 
in two pancreatomised dogs in the year 1889 by Joseph,Yon Mering 
and Oscar Minkowski. 
Paul Langerhans,a German medical student noted that the 
pancreas contains two different groups of cells.The acinar cells 
which secrete the digestive enzymes and cells that are clustered in 
islands. These cells served a second function. In the year 1891 – 
1894, Laguesse described the collection of interacinar cells as a 
gland of secretion within the pancreas. This was later named as 
“Islets of Langerhans”. In the year 1850 Fehling reported his 
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quantitative test for urine sugar. In the year 1908,Benedict 
introduced Benedict’s test for diagnosing urine sugar in 
diabetics.Belgram Meyers first named the secretion as “Insulin” in 
1909.The classical treatment for diabetes mellitus was written by 
Elliot .P. Joslin in the year 1915. 
Fredrick Banting, a Canadian orthopedic surgeon who was 
interested in diabetes along with Charles H.Best, a second year 
medical student worked in the laboratory of Prof.J.J.R.Macleod in 
Toronto7. Insulin was discovered in the year 1922 by Banting and 
Best and they won Nobel Prize for it.Banting and Best with the help 
of J.B.Collip, a skilled chemist produced consistently successful 
preparation of insulin for the treatment of diabetes in humans. This 
revolutionized the treatment of diabetes mellitus and the 
complications. The action of insulin was prolonged by adding 
protamine and thereby reducing its immediate action by Hagedorn 
Era (1937 – 43).Zinc was added to insulin by Fischer and Scott. 
Lente insulin was developed by Halease and Moller et al.In the year 
1982, Human insulin with recombinant DNA technology was 
prepared by Elli Lilly and Goeddal. Oral hypoglycemic drugs came 
into use around 1957. 
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During the 19th and 20th centuries lower limb disease in the 
diabetic patients was described as ‘gangrene in the diabetic foot’ or 
‘diabetic gangrene’. The differentiation between gangrene with 
infection in a limb with normal vascularity and gangrene due to 
vascular insufficiency was made around 1893.Before the advent of 
insulin, surgery was a hazardous task in diabetics. Insulin discovery 
and its use reduced the need for surgical intervention in diabetics. 
Insulin therapy replaced hyperglycemic coma with diabetic foot as 
the major cause of mortality in diabetics. Some hospitals in North 
America initiated prophylactic care and patient education of 
diabetic foot. The role of neuropathy in diabetic foot was neglected 
as ischemia and infection was considered to be the cause of diabetic 
foot at that time8. 
PATHOPHYSIOLOGY OF DIABETIC FOOT 
Diabetics are more prone for foot problems.  
Predisposing factors  
 Changes in vascularity 
 Neuropathic changes 
 Hyperglycemia 
 Infections 
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 HYPERGLYCEMIA 
 Hyperglycemia causes the complications to develop in the 
diabetics through the pathways. 
Polyol pathway 
Due to hyperglycemia, the sorbitol increases and accumulates 
in the cell. It inhibits competitively in the uptake of 
myoinositol.Glucose is shunted through this pathway leading to the 
poor utilization of pyruvate thereby decreasing the production of 
energy. This is called hyperglycemia causing pseudo hypoxia.  
 Protein Glycation  
The reaction between sugars and amino groups produces 
complex glycation products known as Advanced End products of 
glycation.This causes damages to the endothelium increases the 
permeability of the endothelium. This also promotes chemotaxis of 
macrophages and increases the growth factors. Increased cross 
linking of collagen, serum protein trapping leading to enzymatic 
degradation is seen.  
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2. CHANGES IN VASCULARITY 
Atherosclerosis of blood vessels causes ischemia in diabetic 
foot. Peripheral    vascular disease of lower limb is a common 
factor causing poor wound healing leading to ulcers, gangrene, and 
amputation9. 
It commonly occurs as 
 Peripheral Arterial Disease 
 Functional Microangiopathy 
 Hemorrheological abnormalities 
Peripheral Arterial Disease 
Peripheral Arterial Disease is accelerated by hyperglycemia. 
Every 1% increase in levels of HbA1c leads to 25 to 28 % increase 
in the relative risk of PAD.Long standing diabetics for more than 10 
to 15 years have atherosclerotic changes in arteries below the level 
of Profunda Femoris characterised by multiple segmental 
involvement.Peroneal and Tibial arteries are mostly affected 
between knee and ankle.Dorsalis Pedis artery and other foot vessels 
are not usually involved. Establishment of collateral circulation in 
arteries around knee joint is decreased in diabetes 9. 
Risk factors  
 Hypercholesterolemia – Hypertriglyceridemia, 
  11
Decreased levels of HDL 
     Increase in cholesterol lecithin ratio 
 Hypertension 
 Tobacco use 
PATHOGENESIS 
Increased non enzymatic glycosylation of lipoproteins causes 
impairment of LDL binding to the receptors. Glycosylation of LDL 
increases the formation of cholesterol esters and human 
macrophage accumulation which is characterized by formation of 
foam cells in early atheromatous lesions10 
Functional Microangiopathy 
Hyperglcemia leads to thickened basement membrane in the 
capillaries and small vessels. This induction of enzymes glycosyl 
and galactosyl transferase incorporates carbohydrates in basement 
membrane. Increased hydrostatic pressure in the most dependent 
portion causes basement membrane thickening. Though basement 
membrane thickening is seen in glomerulus but not evident in small 
vessels of foot. Failure to dilate and undergo compensatory 
hyperplasia (Functional microangiopathy) is the only abnormality 
made out in diabetic foot patients. 
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Chronic hyperglycemia causes nonenzymatic glycation of 
hemoglobin causes increased affinity for oxygen and decreased 
oxygen release. This causes tissue ischemia leading to endothelial 
damage in capillaries .Non enzymatic glycation of spectrin caused 
by hyperglycemia leads to decreased flexibility of RBC negation of 
FARAH LINDQVIST effect leading to accumulation of RBCs and 
thereby increasing blood viscosity at arteriolar end leading to 
decreased perfusion causing endothelial damage in capillaries. 
Due to persistent hyperglycemia endothelial cell 
dysfunction and smooth cell abnormalities develop in peripheral 
arteries11 resulting in the decrease in endothelium-derived 
vasodilators which causes vasoconstriction. This hyperglycemic in 
diabetes also causes increased thromboxane A2 levels which are a 
vasoconstrictor and platelet aggregator. This in turn increases the 
risk for plasma hypercoagulability12. 
Hemorrheological abnormalities 
Functional alterations in capillary blood flow are seen in 
diabetics which leads to diabetic complications.  Blood and serum 
viscosity is increased. This causes flow abnormalities in 
WBCs,RBCs and platelets. Altered flow characteristics due to 
stiffened RBC membrane and increased RBC aggregation changes 
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the viscosity and causes compensatory rise in perfusion pressure 
leading to increased transudation across capillary beds increasing 
the viscosity further. 
NEUROPATHIC CHANGES 
 55% of diabetics are affected by neuropathy. 
Neuropathy incidence increases along with duration of disease. 
Neuropathic episode increases with episodes of hyperglycemia and 
duration of disease. Neuropathy has sensory, motor and autonomic 
components. 
Sensory neuropathy 
 Proposed mechanisms are  
i) Nitric oxide blocking 
Hyperglycemia, dyslipidemia, insulin resistance and stress 
oxidation all lead to cell damage and endothelial dysfunction and 
other diabetic complications. Hyperglycemia blocks endothelial 
nitric oxide synthetase activation. This leads to increase in the 
levels of reactive oxygen – superoxide. Superoxide dismutases 
enzymatically convert the superoxide into hydrogen peroxide. 
Hydrogen peroxide is converted to hydroxyl radical which is highly 
reactive and damaging in the presence of ferrous or cuprous 
ions.Peroxy nitrate is produced by the binding of superoxide anion 
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to nitric oxide, which is a potent vasodilator. This decreases the 
bioavailability of endothelium derived potent vasodilator.Sulfhydrl 
groups in proteins is oxidized by peroxy nitrate anion which also 
does lipid peroxidation and generation of reactive aldehydes/N2O 
along with the proatherogenic low density lipoproteins production. 
Endothelium regulated vascular function disruption causes 
vasoconstriction, platelet aggregation, intimal growth 
abnormalities, thrombus formation, inflammation13.Vascular wall 
structural protein lipoxidation and glucoxidation causes increase of 
atherogeny through inflammatory cytokine interaction and vessel 
wall characteristic effect. Neuropathy is caused by peripheral nerve 
small vessel (vaso nervorum) atherogenesis. 
(ii)Mailard reaction  
It is slow but complex reaction that leads in production of 
Advanced Glycation End products (AGES), by reacting between 
biomolecules of amino groups and reducing sugars. This reaction is 
considered in diabetic pathophysiology complications to be 
important. This reaction links to protein modification in diabetics 
and in aging process. Lipoproteins and proteins modified by 
Advanced Glycation End products causes’ atherosclerosis. The 
polyol metabolic pathway converts excess glucose into sorbitol by 
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aldose reductase. This consumes NADPH (Nicotinamide Adenide 
Dinucleotide Phosphate) Hexosamine biosynthetic pathway 
activation reduces Nicotinamide Adenide Dinucleotide Phosphate. 
This limits NADPH conversion from Nicotinamide Adenide 
Dinucleotide through inhibition of Glucose 6 Phosphate 
Dehydrogenase enzymatic activity causing decreased Nicotinamide 
Adenide Dinucleotide Phosphate. Decreased NADPH reduces 
glutathione synthesis which is an important antioxidant13 
Increased production of reactive 02 and antioxidant depletion 
causes diabetic foot complications. Neuropathy causes limited joint 
mobility leading to foot deformity. Neuropathy results in callus 
formation due to increase in foot pressure on the pressure points. 
This causes increase in local pressure which along with repeated 
injuries causes local necrosis and ulceration.  
(iii)Neuropeptides 
Nerve Growth substance factor P, Calcitonin gene related 
peptide are neuropeptides that are affected by diabetic neuropathy. 
Growth factor production, cell chemotaxis is caused by these 
neuropeptides which increases the proliferation of cells. Immune 
defense mechanism is modulated by sensory nerves. This is evident 
by decreased leukocyte infiltration in denervated skin. 
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Screening of sensory neuropathy is by physical examination, 
monofilament test for sensory perception –Testing of ten sites with 
monofilament placed on intact skin. Absence of sensation in 3 to 4 
sites indicates sensory neuropathy. Tuning fork test with 128 Hz 
fork for vibration sense perception.  
Motor neuropathy 
Motor neuropathy is due to unequal muscle pull. First muscle 
to be affected is plantar muscle. Distal motor loss causes muscles of 
the dorsum of foot to be pulled unequally and the difference in 
pressure causes cocked up toe. Additional deformity like claw toe 
and hammer toes are also caused by difference in pressure. Claw 
toe is proximal phalangeal dorsiflexion on the lesser 
metatarsophalangeal joints along with proximal and distal 
interphalangeal joint flexion. Hammer toe has proximal MP joint 
deformity and IP joint deformity resulting in a hammer like flexure. 
Hammer toe deformity increases the prominence of metatarsal head 
on the plantar side with claw toes.  
Ill-fitting shoes on these deformities causes break down of 
skin on the increased pressure points. Due to dropping of the 
metatarsal heads there is herniation of the corresponding fat pads 
distally into the base of the toes. Collapsed bone on the plantar side 
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acts as pressure point causing formation of callus on metatarsal 
heads. Risk of ulceration is greatly increased with callus. 
Connective tissue stiffness due to hyperglycemia causing joint 
function impairment and reduces the range of motion as seen in 
equinus deformity.Equinus deformity with ankle joint dorsiflexion 
restriction causes fixed toes. This increases the pressure in the 
forefoot and toe on the plantar side. Motor neuropathy is assessed 
by ankle reflex test. 
Autonomic neuropathy 
Autonomic neuropathy involves sympathetic nervous system 
causing decreased sweating, opening of arterio venous shunts 
leading to altered blood flow regulation and precapillary sphincter 
malfunction. Features of autonomic neuropathy are skin changes, 
nail changes. This reduces blood flow and presents as warm, dry 
skin. This leads to skin break down. 
Skin changes  
Anhidrosis with dry skin and fissures, this should be 
differentiated from fungal infection and other dry plantar skin 
etiologies. Fungal intertrigo is commonly seen in fourth and fifth 
web space.  
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Nail changes  
Distal streaking of nail are changes seen in fungal infections 
like complete asymmetry of the nail plate. Fungal infections are 
assessed by KOH microscopic examination and culture. 
Charcot foot 
It is the late complication of peripheral neuropathy due to 
repeated trauma of insensitive bones and joints in diabetic foot. 
 MECHANISMS 
Neurotrauma:  
Repeated micro trauma due to peripheral sensory loss and 
loss of proprioception damages joint. This is not noticed by the 
diabetic neuropathic patient.This causes inflammatory resorption of 
bone that is traumatised leading that region to weakness Decreased 
motor control increases the pressure on certain joints causing 
microtrauma.  
Neurovascular:  
Autonomic neuropathy in diabetic foot patients along with 
sensory neuropathy in joints causes dysvascularity leading to 
hyperemia. This increases osteoclastic resorption of bone leads to 
destruction of bone. 
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Joint Involvement 
Most common joint involved in charcot foot is 
tarsometatarsal joint wherein the medial joint is more affected than 
lateral joint in about 60 percentage. Metaatarsophalangeal 
involvement is about 30%.Ankle involvement in 10%. Most of them 
have undergone some form of minor trauma. 
Clinical features 
 Redness, 
 Swelling,  
 Deformity of foot. 
 Increased temperature  
 Foot ulcer 
 Dislocation of bones and joints without trauma 
Classification of Charcot foot 
Sanders and Frykberg have classified the Charcot’s foot 
based upon the neuropathic osteo-arthropathy.They described the 
pattern of joint and bone destruction. 
1. Forefoot   is mainly involved seen in 26 -67%, Metatarsal 
head ulcers are seen 
2. Midfoot collapse.It is seen in 15 – 48%.It involves 
tarsometataarsal joints 
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3. Midfoot collapse.It is seen in 32%.It involves 
calcaneocuboid, Naviculocuneiform, and talonavicular joints. 
4. Unstable Ankle seen in 3 to 10% of the patients .It involves 
subtalar and ankle joint. 
5. Calcaneal involvement. It is rarely seen. 
Dounis classification of neuro-osteoarthropathy(1997) 
Type I : Forefoot involvement  
Type II: Midfoot collapse 
Type III:  Rear foot is involved and is subclassified as : 
IIIa: Ankle instability 
IIIb : Varus deformity.Involves Subtalar joint 
IIIc : Loss of weight bearing 
In acute phase, it is difficult to distinguish cellulitis, 
Charcot’s foot and osteomyelitis. Radiography of Charcot shows 
Fractures, Bone destruction, periosteal new bone formation. 
Healing is delayed taking about 6 to 9 months .In this period the 
foot becomes distorted into clinically visible Charcot foot – Rocker 
bottom foot deformity. 
Eichenholtz‘s Classification describes the nature of joint 
destruction process clinic- radiologically. 
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Stage 0:  Joint edema is seen clinically, but x rays are negative. 
Stage 1(Developmental stage): Dislocation of joints with 
fragmentation of bones seen on x ray. 
Stage 2(Coalescence stage): Local edema is decreased, Fragments 
coalese along with absorption of bony debris. 
Stage 3(Reconstructive stage):  Local edema is absent, but 
fracture fragments undergone consolidation and remodeling with 
deformity. The foot is stable. 
4. INFECTIONS 
Infection is defined as the presence of a pus secretion or  2 
symptoms or signs of inflammation like palor, rubor, dolor, calor. 
Diabetic patients are more prone for infections than normal 
individuals. In normal people the flora in the leg and foot are 
restricted due to  
I. Less than optimum skin temperature for the survival of 
human pathogens. 
II. Antimicrobial effect of skin metabolic products 
III. Dorsum of foot and leg have acidic surface 
IV. Thick stratum corneum 
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Most common infections seen in diabetics are bacterial and fungal. 
RISK FACTORS 
 Vascular insufficiency 
  Peripheral Neuropathy leads to repeated trauma 
 Decreased host resistance 
 Decreased leukocyte mobilisation 
 Defect in formation of reactive oxygen metabolites 
Common organisms are aerobes and anaerobes. Usually the 
infections in diabetes mellitus are polymicrobial. 
1. Gram - ve bacilli 
 Proteus mirabilis 
 Escherichia coli 
 Pseudomonas aeroginosa 
 Enterobacter aerogenes 
2. Gram +ve cocci 
 Staphylococcus aureus 
 Group B streptococcus 
 Enterococcus 
 Peptostreptococcus magnus 
 Peptostreptococcus.anaerobes 
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3. Anaerobes 
 Gram negative bacilli 
 Bacillus Fragilis 
 Bacillus ovatus 
 Bacillus ureolyticus 
GRAM POSITIVE BACILLI 
Clostridium bifirmentans Of all these organisms, Staph 
aureus and beta hemolytic strepytococcus,coagulase negative 
staphylococcus are most important. Ischemia and neuropathy both 
mimic inflammatory signs, so the following signs like friable 
tissue, undermined wound edge, foul smelling discharge indicate 
infection. Diabetic foot infections mostly do not cause systemic 
manifestations like pyrexia or leukocytosis. If they are present they 
indicate the severity of infections. Infection can be a major threat to 
limb and life if not treated aggressively. Superficial cultures from 
wound are not helpful .Tissue specimens are preferred to wound 
swabs as they are more sensitive and specific. Life threatening 
infections is characterised by bullae,ecchymoses, soft tissue 
crepitus and ascending infection  progressing to necrotising fascitis 
caused by multiple bacteria,aerobes,anaerobes,microaerophilic 
bacteria.Necrotising fascitis spreads rapidly along the fascial plane 
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involving the perforator supplying the skin. This leads to ischemia 
and gangrene of skin and fascia. This is associated with high 
mortality due to septicemia. Other common problem in diabetic 
foot is osteomyelitis. It is difficult to distinguish osteomyelitis from 
arthropathy.X ray changes in osteomyelitis are focal 
osteopenia,lucency of the cortex or medullary bone. In Chronic 
osteomyelitis sequestration of dead bones is seen. 
CLASSIFICATIONS OF DIABETIC FOOT 
Once diabetic foot ulcers develop clinical staging is 
important. Most common classification used for diabetic foot ulcer 
is Meggit Wagner classification.This classification is based on 
wound depth, presence and location of wound infections. Grades 
range from 0 to 6.University of Texas classification is used 
commonly in wound care clinics13 
Meggit Wagner classification 
Grade 0 – No ulcer in high – risk foot 
Grade 1 – Superficial ulcer involving the full skin thickness but not 
underlying tissues 
Grade 2 – Deep ulcer, penetrating down to ligaments and muscle, 
but no bone involvement or abscess formation 
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Grade 3 – Deep ulcer with cellulitis or abscess formation, often 
with osteomyelitis 
Grade 4 – Localized gangrene 
Grade 5 – Extensive gangrene involving the entire foot 
University of Texas Classification 
Grade I A – Noninfected,nonischemic superficial ulceration 
Grade I B – infected, nonischemic superficial ulceration 
Grade I C – ischemic, noninfected superficial ulceration 
Grade I D – Ischemic and infected superficial ulceration 
Grade II A –  Noninfected, nonischemic ulcer that penetrates to 
capsule or bone 
Grade II B –  Infected,nonischemic ulcer that penetrates to 
capsule or bone 
Grade II C –  Ischemic, noninfected ulcer that penetrates to 
capsule or bone 
Grade II D –  Ischemic and infected ulcer that penetrates to 
capsule or bone 
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Grade III A -  Noninfected, nonischemic ulcer that penetrates to 
bone or a deep abscess 
Grade III B –  Infected, nonischemic ulcer that penetrates to 
bone or a deep abscess 
Grade III C –  Ischemic, noninfected ulcer that penetrates to 
bone or a deep abscess 
Grade III D -  Ischemic and infected ulcer that penetrates to 
bone or a deep abscess 
PEDIS classification 
 It is developed by International Working Group of Diabetic 
Foot based on the following categories.(Research oriented) 
 Perfusion 
 Extent 
 Depth/tissue loss  
 Infection  
 Sensation  
Infectious Diseases Society of America 2004 guidelines  
Diabetic foot wound with infections are sub classified as 
mild, moderate and severe.  
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Mild – Skin and subcutaneous tissue only involved with more 
than 2 manifestations of inflammation (purulence or 
erythema,pain,tenderness,warmth or induration);any cellulitis or 
erythema extends < 2cm around the ulcer; no local complications or 
systemic illness 
Moderate – affecting deeper tissues or extensive 
involvement. Infection in a patient who is systematically well and 
metabolically stable but has more than 1 of the following: cellulitis 
extending >2cm;lymphangitis;spread beneath fascia; deep tissue 
abscess;gangrene;muscle,tendon,joint, or bone involvement. 
Severe – Systemic signs of infection or metabolic instability. 
Infection in a patient with systemic toxicity or metabolic instability 
(eg, fever, chills, tachycardia, hypotension, confusion, vomiting, 
leukocytosis, acidosis, hyperglycemia or azotemia) 
S(AD)AD classification grades 5 categories – Size, 
(Area,Depth), Sepsis, Arteriopathy and  Denervation on a four point 
scale – 0 to 3. 
INVESTIGATIONS 
Blood tests – Fasting blood sugar > 120 mg 
Postprandial blood sugar >180 mg indicative of diabetes 
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Glycosylated Hemoglobin assay - HbA1c – Hemoglobin 
undergoes nonenzymatic condensation of glucose of free amino 
groups of globin molecule,due to chronic hyperglycemia.So higher 
the level of hyperglycemia higher the level of glycosylated 
hemoglobin. Since the half-life of RBC is 120 days this reflects the 
metabolic control of diabetes over the last 4 months.Major part is 
HbA1c about 6% remaining HbA1a and HbA1b.The normal range 
is 5 – 8%..Anything more than 12 – 15% reflects poor control of 
diabetes. 
Serum Fructosamine 
 This is due to glycosylation of serum proteins .This 
reflects the glycemic control of last 2 weeks. 
Culture and sensitivity tests – pus from infected area 
cultured for microorganisms and sensitivity to antibiotic is tested. 
X–ray of foot  
X- ray detects the presence of osteomyelitis , bone 
destruction commonly seen at metatarsophalangeal joints or 
interphalangeal joint of great toe.Gas in tissues indicates anaerobic 
infection.Osteoporosis of bones can be made out.Calcification of 
vessels can be made out. 
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Ankle Brachial Index (ABI) 
ABI measured with pocket Doppler probe of 4 to 10 
MHz.Brachial systolic pressure of both arms is measured. Ankle 
systolic pressure measured by applying BP cuff over the ankle 
above the malleolus and both posterior tibial and Dorsalis pedis 
pressure is measured by not applying pressure on the probe and 
maintaining a beam vessel angle of 60 degree. The highest ankle 
pressure divided by highest brachial pressure – Ankle Brachial 
Index. Normal value is 1 – 1.2. Less than 0.9 ABI indicates 
occlusive arterial disease.ABI less than 0.3 or ankle systolic 
pressure less than 50 mm Hg indicates critical limb ischemia. 
Change of ABI value more than 0.15 indicates significant 
narrowing and angiography evaluation needed. Medial calcification 
of vessels make arteries incompressible resulting in high ABI 
values more than 1.2.In these cases toe pressure is used. 
Duplex scanning with ultrasound analysis 
Duplex scanner use the combination of real time B mode 
USG imaging of the arterial wall along with pulsed Doppler 
imaging and examine the flow patterns in the arterial lumen at 
specific sites. It is a simple, low cost and useful method. It 
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determines the site and degree of obstruction. Patency of vessel 
after revascularisation is seen. 
ANGIOGRAPHY 
Percutaneous femoral angiography 
It is used for evaluating the vascular supply of leg and 
foot.Angiography gives information regarding the patency of the 
vessel ,direction of blood flow, site of stenosis. It shows diffuse 
atherosclerotic disease of tibial and peroneal arteries, site of 
stenosis. Complications are thrombosis, peripheral embolization 
and allergic reactions to contrast.  
Digital Subtraction Angiography 
It is a digital fluoroscopic technique  for clearly seeing blood 
vessels in bony or soft tissue background. The images are taken 
after injecting contrast by subtracting pre – contrast image or mask 
image. Digital Subtraction Angiography can be done on OPD basis 
with iv contrast.DSA has better contrast resolution. Cost is less 
compared with conventional angiography.DSA demonstrates small 
vessels distal to an obstruction .DSA has poor spatial 
resolution.DSA has advantage of simultaneous endovascular 
intervention also. Disadvantage in DSA is in diabetics the risk of 
contrast induced nephropathy is high in the prevalence of renal 
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insufficiency. Therefore patients with renal impairment are given 
pre – procedural intravenous volume expansion, Metformin is 
stopped prior to Digital Subtraction angiography as it causes lactic 
acidosis. In patients with severe occlusive disease when the 
concentration of contrast is less; visualization of pedal vessels is 
limited. 
TREATMENT 
Management of diabetic foot 
 Control of risk factors 
  1. Stop smoking 
  2. Control of hypertension,hypercholesterolemia 
Infection  
In management of diabetic patients with infected feet, 
following factors are to be considered – extent of tissue necrosis 
and gangrene, extent of bone involvement, vascularity of foot, 
peripheral neuropathy, presence of foot deformity, metabolic 
control of diabetes .Metabolic control of diabetic state to be 
aggressive and achieved by insulin therapy. Wound debridement – 
all necrotic tissues should be debrided until healthy bleeding is 
reached. Wound cleansing after surgical debridement acts as a 
complement to systemic antibiotics and reduces the incidence of 
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continued infection. The irrigation solution used are normal 
saline,povidone iodine solution. Normal saline alone is effective in 
reducing bacterial counts16.All purulent material should be drained; 
copious normal saline wash should be given. Daily debridement 
should be done if needed. 
Antimicrobial therapy based on culture reports is started and 
multiple debridements may be necessary in the diabetic foot prior 
to reconstruction. Adequate removal of all necrotic tissues is 
associated with quicker healing times.Debridements increases the 
rate of limb salvage to 89.8%17. In presence of severe infection 
with sepsis higher antibiotics like Imipenem,Ticarcillin 
clavulanate,ampicillin sulbactum have activity against anaerobic 
bacteria. Metronidazole has activity against gram negative 
anaerobic bacilli.B.fragilis is treated with clindamycin. With severe 
infections in presence of septicemia, combination of 2 antimicrobial 
agents is started as preliminary empirical therapy, later the 
antibiotics are changed according to the culture and sensitivity 
reports.  
Offloading 
Pressure relief on ulcers known as offloading is always part 
of the treatment plan. Bony deformity and displacement of soft 
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tissues leads to high plantar pressure and causes non-healing ulcer. 
Measurement of pressure between the foot and ground and between 
the foot and shoe tells whether the patient has adequate load relief 
during and after ulcer healing. Offloading with total contact cast 
accelerates ulcer healing. Neuropathic ulcers that have resisted 
healing for many months heal in 6 weeks of time with total contact 
cast. Total contact cast is successful when properly applied and 
changed weekly.Crutches,bed rest, wheel chairs are not effective 
for offloading without direct intervention of the foot. Different kind 
of braces, sandals, modified shoes are available for offloading the 
plantar surface and immobilizing the foot and ankle. Once the 
infection is controlled, and if the ulcer is small in size, protective 
and therapeutic footwear insoles, orthosis,total contact cast, bed 
rest15.  
Revascularization 
Revascularization in diabetic foot patients with peripheral 
arterial disease has a limb salvage rate of 85%18.Patients with ABI 
less than 0.5 after appropriate vascular imaging with infection and 
non-healing ulcers, earlier vascular intervention is required. Digital 
Subtraction Angiography is the standard imaging modality for 
evaluating Peripheral Arterial Disease when revascularization is 
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planned. The important task for any revascularization procedure is 
to achieve at least one open infrapopliteal artery down to the foot. 
Standard treatment for patients is femorodistal bypass with 
autogenous saphenous vein graft. Prosthetic grafts can also be used 
but with decreased patency rates. Endovascular treatment is 
preferred in patients with borderline toe pressures and short lesions.  
Bypass is used in patients with long occlusions. Endovascular 
therapy in infrapopliteal arterial disease is used as the first line 
revascularization method for improving ulcer healing and to 
salvage the limb. There are good results and patency rates with 
endovascular treatment of PAD with critical ischemia19.In distal 
bypass procedures, the clamping of vessels should be avoided to 
prevent any lesions distal to the anastomosis. This makes distal 
anastomosis challenging in the distal outflow vessels which are 
heavily calcified. In these cases balloon obstruction or tourniquet 
ischemia improve visibility during the anastomosis. The best graft 
material in distal bypass is autologous saphenous vein graft as it 
has better patency rates and also resists infection in comparison to a 
prosthetic graft. Timing of the revascularization inpatients with 
infection is usually delayed 2 to 5 days to control the infection. The 
debridement is done first and revascularization later. Simultaneous 
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revascularization at the time of initial debridement helps in 
increasing the blood flow. 
Negative pressure wound therapy is used to fasten healing. 
The prerequisite for negative pressure wound therapy is that there 
is sufficient blood supply for ulcer healing. Negative pressure 
wound therapy does not replace surgical wound debridement and 
measures to improve blood circulation. Negative pressure wound 
therapy is effective than other available local wound treatments in 
patients without significant infection. 
ADJUVANT PROCEDURES 
Tendoachilles lengthening 
The insensate foot gets deformed by the action of the 
Gastronemius soleus muscles which is the most powerful muscle in 
the leg represented by the tendoachilles.Contracture of the 
tendoachilles results in the equinus deformity of the foot. This 
prevents dorsiflexion in ankle joint. While walking the angle 
between the tibia and foot is about 11 degrees. The midfoot 
collapses due to loss of normal movements.This causes rise in the 
pressure from the great toe ball to the midfoot. The heel contact 
phase is reduced along with the midstance.This caused the ball of 
the foot to be in contact with the floor for a longer duration.In 
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patients who have lost the foot sensation, increases the risk for 
forefoot ulceration leading to non-healing ulcer unless equinus 
deformity is corrected.  
In patients affected  with diabetes for many years, neuropathy 
develops. Electron microscopic studies of tendoachilles shows 
collagen changes which causes the contracture of the tendoachilles. 
Tendoachilles lengthening is done and tendon is repaired by 
nonabsorbable sutures in the open procedure. Percutaneous 
lengthening is done by small incision and the foot is manipulated to 
bring about a dorsiflexion of 5 to 10 %.  
When performing tendoachilles tenotomy or combining 
tendoachilles lengthening with plantar midfoot exostectomy, 
Achilles tendon work is done first followed by osseous work. For 
hind foot or midfoot reconstructive arthrodesis osseous work is 
done first and tendoachilles lengthening is done later. The 
arthrodesis procedure is done in the supine position and the patient 
turned in prone position and tendoachilles lengthening is 
performed. Achilles tendon lengthening or tenotomy is also 
recommended for recurrent plantar ulcer following trans metatarsal 
amputations. In Trans metatarsal amputations excessive dynamic 
forces acts on the short foot to cause recurrent plantar ulcers. 
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Achilles tendon lengthening or tenotomy reduces the propulsive 
force stride length and shear force that contribute to development 
of ulcer. Stride length is a contributing factor for the development 
of ulcers in neuropathic foot. There is less pressure and force 
transmitted to the distal aspect of the plantar foot when the stride 
length is shortened to 14 inches. Achilles tendon lengthening or 
tenotomy results in shortening of stride length.  
Subtotal calcanectomy 
In ulcers around the hind foot with osteomyelitis of the 
calcaneum,resection of the calcaneum upto one third of the 
posterior calcaneum is performed so that the soft tissues is freed 
and the defect can be closed primarily.Resection of the major 
portion of calcaneum does not prevent the patient from bearing 
weight on the foot. Subtotal calcanectomy is reported to be superior 
to total calcanectomy because it provides a stable foot.Subtotal 
calcanectomy is a reliable adjunctive procedure for maintaining the 
foot stability.Tendoacilles is erased from the calcaneum and 
attached back to the stump of the calcaneum.If there is 
osteomyelitis of the calcaneum the tendoachilles is removed 
circumferentially from the calcaneum,this does not allow the 
tendon to retract back. Immobilising the leg for 6 weeks causes 
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fibrosis of the tendon to the surrounding tissues and the function of 
tendoachilles is maintained. 
Ostectomy for Charcot’s joint 
Plantar ulcerations are common in charcot’s joint disease. 
Large portions of the bone migrate to the plantar aspect of the foot 
with secondary prolapse of the medial or longitudinal arches 
producing the classic Rocker Bottom foot. This foot concentrates 
enormous amount of pressure in isolated areas causing pressure 
points that results in ulcerations. Typical midfoot break down 
associated with Charcot joint disease is classified as type I 
Charcot’s joint based on Brodsky classification. Patients that are 
candidates for surgery fall in Eichenholtz stage III Charcot’s 
disease when bony healing is taking place20. Midfoot ostectomies 
with saucerisation of bone is done in cases of plantar deformities – 
Charcot midfoot collapse (Charcot’s Rocker Bottom foot). The 
defect can be closed primarily.Saucerisation prevents local 
recurrence when performed along with tendoachilles lengthening. 
Charcot joint stabilization 
Arthrodesis for stabilization of charcot joint done are midfoot 
procedures and hind foot procedures. When joints in mid foot 
coalesce bony prominences are removed with ostectomies. In 
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Eichenholtz stage II Charcot bony prominence is removed to 
eliminate non healing plantar ulce .Non healing ulcer in stage II can 
be treated with Arthrodesis of mid foot.Arthrodesis is considered 
once ostectomy fails. In stage II disease there is instability so 
arthrodesis helps. In stage III Eichenholtz, arthrodesis is rarely 
necessary because there is bony consolidation. In severe hind foot 
deformity which is not corrected by ankle foot orthoses or braces 
with chronic ulceration; arthrodesis is indicated in hind foot. The 
goal in this surgery is to maintain structural stability and to 
maintain plantargrade position of the foot. Success of arthrodesis 
depends on adequate vascularity, absence of infection, nonweight 
bearing and removal of pressure points. These procedures may be 
used as an alternative to amputation in salvaging the foot.  
Great toe ulcers 
The paralysis of the EHL muscles leads to ulcer on the great toe in 
neuropathic patients.These are corrected by fusion of the 
interphalangeal joint.The great toe is incised by two elliptical 
incision about an inch over the dorsal aspect of the Ip joints.EHL 
tendon is cut and the joint is exposed.The cartilage is excised from 
the base and head of the phalanx.The osteotomy is done.The bones 
are then aligned with two k wires in a criss cross manner. This is 
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kept for about 3 weeks. The fibrosis which results is satisfactory. 
The digits are fixed in improvised position.Localised procedures to 
close the wound on the tip of the toe can be performed now. 
Hallux arthroplasty – two incisions which intersect each other 
on the dorsal aspect of the great toe are put.EHL tendon is divided 
and the Ppx head is delivered and resected and wound is closed 
with a toe bandage in straight alignment. This bandage is continued 
till the fibrosis occurs for about 6 weeks. This correction results in 
healing of the ulcers on the great toe. Ulcers beneath the head of 
the 1st metatarsal caused due to prominence of the 1st metatarsal 
bone due to high instep foot. This is repaired by removal of one or 
both the sesamoid bones. This reduces the pressure on the head of 
the 1st metatarsal and decreases the recurrence of the ulcer. The 
sesamoid can be directly approached through the wound or through 
a medial incision in the MP joint.The capsule is opened by an 
incision and median digital nerves and long flexor tendon are to be 
protected.  
Flap cover 
Soft tissue reconstruction in the diabetic foot is challenging 
as the area is characterized by tight skin and poor blood supply. 
SSG on the weight bearing areas are unrealistic and mostly fails. 
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Flap selection is based on multiple factors like location, size of the 
defect to be covered, type of deficient tissue components, presence 
of infection, weight bearing, sensory needs, donor site and its 
morbidity and logistics of operation21. Muscle flaps have been 
preferred for decades; they conform better to three dimensional 
wounds obliterating the dead spaces and decreasing the risk of 
infections. Muscle flaps are believed to improve vascularity. 
Muscle flaps bring in antibiotics and oxygen delivery to the 
contaminated wounds.Fasciocutaneous flaps have also been used 
successfully for the coverage of chronic wounds.  
Local flaps are used when possible as they reduce the operating 
time as microsurgical anastomosis is not required, patient can be 
operated under regional anaesthesia.Potential risks in local or regional 
flap are regional hypertension and distal tip necrosis22. The use of 
local flaps to cover the defect has been applied but there use is limited 
by the availability of healthy well vascularized tissue in a diseased 
foot and the size of the defect23. First successfully performed free 
groin flap to reconstruct dorsal foot defect by O Brien and Daniel 
Taylor four decades ago. Microsurgical techniques have become one 
of the essential pillars of foot and ankle reconstructive procedures. 
The successful treatment with  diabetic foot ulcers by microsurgical 
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procedures are now done with a better understanding of 
biomechanical requirements concern for durability, donor site 
morbidity and shoe fit.  
A transferred flap with micro vascular anastomosis is highly 
vascularized with its own intrinsic blood vessels in contrast to local 
flaps which are relatively ischemic in their distal portion. 
Transposition flap is most frequently used flap to cover exposed 
bone, joint or tendon only. Rest of the defect is covered with 
SSG.The flap is taken from the site that is most mobile and that has 
a definable perforator at its base. The rotation flap is useful on the 
plantar aspect of the foot where the flap is elevated off the plantar 
fascia and rotated into position. 
V – Y plantar flap – forefoot skin, fat and fascia is advanced 
in a V-Y fashion either singly or in pairs. Wounds up to 4 to 5 
cm3.Medial plantar artery flap is useful foe heel pad reconstruction. 
The donor site must be skin grafted. The instep should be non-
weight bearing and unlike a Charcot’s midfoot collapse where the 
skin graft will not be taken. The instep of the foot is elevated as a 
fasciocutaneous flap based on the medial plantar artery and 
transposed posteriorly to cover the heel.Sural artery flap 
(Retrograde sural artery) is used for ankle and posterior heel 
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defects. A median sural artery is seen coursing with the sural nerve 
in most cases the arterial component is a plexus of vessels with the 
sural nerve and receives retrograde flow from a peroneal perforator 
5 cm above the lateral malleolus. The artery first courses above the 
fascia and then goes deep to the fascia at the mid-calf level while 
accompanying lesser saphenous vein. The insert of the flap is 
critical to avoid kinking of the pedicle. During the healing period, 
the flap and heel is offloaded. Donor defect is skin grafted; there is 
a sensory loss on the lateral aspect of the foot. 
Micro vascular composite tissue transplantation (free flaps) – 
Large foot wounds with bone or tendon exposure are best 
reconstructed with free flaps. Anterolateral thigh flap is a 
septocutaneous flap based on perforators originating from 
descending branch of lateral circumflex femoral artery. The ALT 
flap is well accepted and supplies large amount of subcutaneous fat 
and skin on a safe and reliable pedicle with no functional donor site 
morbidity. The flap can be raised as a sensate flap with the lateral 
femoral cutaneous nerve and also as a flow through flap. The flap 
can be thinned and tailored for the particular defect. 
Radial forearm flap – It is a good option for dorsal foot 
wounds. It is a thin and pliable and can be harvested with a sensory 
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nerve. The radial artery with venaecomitantes provides vascular 
pedicle of about 14 cm length. The donor site is skin grafted. 
Para scapular flap is based on the circumflex scapular artery. 
It is used for large defects. It is an insensate flap and also bulky. 
The flap has to be thinned at a later date. 
Gracilis muscle flap – it is a thin flat muscle located on the 
medial thigh extending between the symphysis pubis and medial 
tibial condyle lying between the adductor longus and Sartorius 
muscle anteriorly and semimembranosus posteriorly. Functions as 
an adductor of the thigh but is expendable due to compensation 
made by adductor magnus and longus.Vascular supply is from the 
terminal branch of the medial circumflex femoral artery. Motor 
innervation is from the anterior branch of the obturator 
nerve.Gracilis muscle can be tailored to any size and is supple and 
pliable. Contour improvement occurs early.  
Latissimus dorsi muscle flap – It is a large flat muscle 
covering mid and lower back. It is the first choice in large defects 
of the foot involving entire sole or complex defects. The muscle is 
bulky but contour correction over time is satisfactory. It has a long 
reliable pedicle based on the thoracodorsal artery which enters the 
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undersurface of the muscle 5 cm from the posterior axillary fold. 
Donor site morbidity can include shoulder dysfunction, weakness 
and pain, so it is used with caution in patients with crutch 
dependence 
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MATERIALS AND METHODS 
TYPE OF STUDY 
It is a retrospective clinical study. 
STUDY SETTING 
The study was conducted in the Department of Plastic and 
Reconstructive Surgery, Rajiv Gandhi Government General 
Hospital and Madras Medical College, Chennai over a period from 
January 2003 to February 2014. 
SAMPLE SIZE 
All the diabetic foot patients who got admitted and had 
undergone revascularization and subsequently had foot defects in 
need of reconstruction of foot or foot remnants from January 2003 
to February 2014 were included in our study which includes 78 
cases and it includes 10 females and 68 males. 
INCLUSION CRITERIA 
1. All the diabetic foot patients who had undergone 
revascularization and had foot defects, subsequently in need 
of reconstruction of foot or foot remnants. 
2. All revascularised diabetic foot patients with PT/ INR around 
1.5. 
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EXCLUSION CRITERIA 
1. Those who have undergone revascularization but with co-
morbid illness complicating anesthesia for foot reconstruction 
2. Patients with renal failure 
3. Age more than 70 years 
METHODOLOGY 
Patients who underwent revascularization of diabetic foot and 
in need of foot reconstruction were selected in the period from 
January 2003 to February 2014. Prior permission and no objection 
certificate were obtained from the Head of Department and the 
study details were presented to the Institutional Ethical Committee 
and permission obtained. A detailed proforma is made which 
includes general information of the patient, any co- morbid illness, 
smoking history, treatment history, provisional diagnosis, general 
and local examination and investigations undergone. Relative 
information was filled in a proforma and information was taken from case 
records. 
Following information are noted from the case records – 
1. Type of revascularization procedure  
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2. Latency period (period before embarking on reconstruction 
following revascularization)  
3. Number of debridement done prior to reconstruction  
4. Adjuvant procedures performed  
5. Foot reconstruction procedure 
Various types of flaps and other reconstructive procedures 
were done by the experienced surgeons only after detailed analysis 
of the case by the reconstructive surgery team after taking into 
consideration of all the factors. Patients were well informed about 
the advantages and complications of the procedure. Those patients 
who were assessed by the expert team to have higher probability of 
failures were not taken up for reconstructive procedure and were 
asked to undergo primary amputation. 
All the patients are preoperatively evaluated with following 
investigations         
 Complete Blood count,  
 Renal Function Tests - *Blood Urea 
    *Serum Creatinine,  
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 Blood sugar  
* Fasting Blood Sugar 
  * Post Prandial Blood Sugar 
  * HbA1c 
 PT - INR 
 Screening for Sexually Transmittable diseases  
                          *  HIV,  
                          *  HbsAg,  
                          * VDRL, and  
 MR Angiogram / Digital Subtraction Angiogram (optional)  
Before taking up reconstructive procedures in these patients 
their critical limb ischemia was addressed by revascularization 
either angioplasty or a bypass procedure and then reconstruction 
was planned.  
All the patients had ulcers with poor potential for healing 
before the revascularization procedure. Once the revascularization 
was done, the patients developed regional vascular insufficiency 
characterized by poor wound granulation,this was treated with 
dressings,debridements.Negative pressure wound therapy was used 
in this period . Off- loading techniques were also used which took 
many days and that period was used to improve the patient’s 
  50
general condition both physically and mentally. They were 
transfused with blood and blood products if needed. 
 Culture and sensitivity of the wounds were done and 
appropriate antibiotics were administered and once the infection 
was controlled, with a favourable wound bed reconstruction was 
planned and the perforators of the flaps and recipient vessels were 
assessed by hand held Doppler of 8 to 10 MHz.The need for 
adjunctive procedures like Tendoachilles lengthening, Ostectomies, 
gap arthroplasties and tenotomies was also assessed as adjuvant 
procedures form an integral part of any definitive reconstructive 
procedures. Procedures were done using regional or general 
anesthesia under cardiac monitoring. Postprocedure, 
Inj.Dexamethasone, low molecular weight Dextran 40 and a proton 
pump blocker were given to  all the patients for 48 hours and the 
limb of the patients were immobilized with posterior popliteal slab. 
The patients were discharged after 1 week and then followed up 
periodically to check for postoperative complications.  
Follow up Procedure: 
 At weekly interval for one month and followed by once 
a month for 6 months and twice a year thereafter. 
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Assessment of Outcome: 
     Post - operative complications were assessed. Complications 
include  
- wound infection,  
- hematoma and seroma  
- flap necrosis,  
- wound dehiscence,  
- ulcer recurrence 
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DATA MANAGEMENT AND ANALYSIS 
All data were reviewed at periodic intervals and all raw data 
are finally computed at the end of the study to find out the 
outcomes of surgery in terms of post-operative complications. 
Statistical analysis was done .The graphs were produced using 
Microsoft Excel. 
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RESULTS 
 TABLE 1 – AGE DISTRIBUTION 
 
 
 
Age in years Number Percentage 
45 to 50  10  12.82% 
51 to 55  27  34.6% 
56 to 60  34  43.58% 
61 to 65  7  8.97% 
  54
Out of 78 patients included in the study, Maximum number of 
patients i.e., 34(43.58%) were in the age group between 56 to 60 
years, 27(34.6%) were in the age group of 51 to 55 years, 
10(12.82%) were in the age group of 45 to 50 years and the 
remaining 7 (8.97%) fall in the age group between 61 to 65 years. 
Mean age found in the study is 57.2 years 
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TABLE – 2 SEX DISTRIBUTION 
Sex Number Percentage 
Male  68  87.17% 
Female  10  12.82% 
 
 
In our study, majority of the patients i.e., 68(87%) were 
males and the rest 10(13%) were females 
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TABLE – 3.SMOKING 
Smoking Number Percentage 
Yes  49  62.82% 
No  29   37.17% 
 
 
Majority of the patients were smokers i.e., 49(62.82%) and 
29(37.17%) were non smokers. 
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TABLE – 4- TYPE OF REVASCULARISATION 
 
Type of 
revascularisation 
Number Percentage 
Angioplasty  42  53.84% 
Bypass  36  46.15% 
 
 
Of the 78 patients, 42(53.84%) underwent angioplasty and 
36(46.15%) underwent bypass procedures for revascularisation 
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TABLE – 5 – NUMBER OF DEBRIDEMENTS 
Number of 
debridements 
Number Percentage 
1  2  2.56% 
2  54  69.23% 
3  22  28.2% 
 
 
Most of the patients in our study has underwent two 
debridements 54(69.23%), while 22 (28.2%) has underwent 3 
debridements and 2 of them has undergone single debridement.  
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TABLE -6- LATENCY PERIOD 
Latency period in days Number Percentage 
</= 20  2  2.56% 
21 – 30  28  35.89% 
31 – 40♣ 27  34.61% 
41 – 50  13  16.66% 
51 – 60  8  10.25% 
2.56%
35.89%
34.61%
16.66%
10.25%
0.00%
5.00%
10.00%
15.00%
20.00%
25.00%
30.00%
35.00%
40.00%
</= 20 21 – 30 31 – 40 41 – 50 51 ‐ 60
Latency Period
Percentage
 
The average latency period found in our study is 35.36 days. 
Most of the patients 28(35.89%) in our study show a latency period 
between 21 to 30 days 
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TABLE 7 – VAC 
VAC Number Percentage 
Yes  42  53.8% 
No  36  46.2% 
 
53.80%
46.20%
42.00%
44.00%
46.00%
48.00%
50.00%
52.00%
54.00%
Yes No
VAC
 
In our study 42(53.8%) of the cases underwent Negative 
Pressure Wound Therapy in the latency period. 
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TABLE 8 – RECONSTRUCTION PROCEDURES 
Type of procedures No. of patients Percentage 
LD  19  24.35% 
RFF  12  15.38% 
G  6  7.69% 
PSF  5  6.41% 
ALT  4  5.12% 
MP  2  2.56% 
SFC  11  14.10% 
RSSA  9  11.53% 
IFC  5  6.41% 
PF  5  6.41% 
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Of the 78 patients 19(24.35%), 12(15.38%), 6(7.69%), 
5(6.41%), 4(5.12%), 2(2.56%), 11(14.10%), 9(11.53%), 5(6.41%), 
5(6.41%) underwent Latissimus Dorsi flap,Radial free Forearm 
flap, Gracilis flap, Parascapular flap, Anterolateral thigh flap, 
Medial Plantar artery flap, Superior Fasciocutaneous Flap, Reverse 
Superficial Sural Artery flap, Inferiorly based fasciocutaneous flap, 
Perforator flap. 
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TABLE 9 – ADJUVANT PROCEDURES 
Adjuvant procedures No.of patients Percentage 
TAL  7  8.97% 
Ost  9  11.53% 
TEN  3  3.84% 
Nil  59  75.64% 
TAL, 7
Ost, 9
TEN, 3
Adjuvant procedures
 
Of the 78 cases, 59 did not undergo any adjuvant procedures, 
while 7(8.97%),9(11.53%),3(3.84%) has undergone Tendo Achilles 
Lengthening, Ostectomy, Tenotomy. 
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TABLE 10 – COMPLICATIONS 
Complications Number 
Hematoma  2 
Flap necrosis  1 
Partial flap necrosis  1 
Wound dehiscence  1 
Ulcer recurrence  2 
Total  7(9%) 
 
Complications 
Hematoma, 2
Flap necrosis, 1
Partial  flap 
necrosis, 1
Wound dehiscence, 
1
lcer recurrence, 2
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Complications were found in 7( 9%) of the patients, of which 
2 of them had ulcer recurrence, 2 of them had hematoma,1 had 
wound dehiscence,1 had partial flap necrosis,1 had flap necrosis. 
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DISCUSSION 
The mean age found in our study group is 57.2 years. This is 
similar to other studies like Tae Suk Oh et al, C.Randon et al,Baek 
Kyu Kim et al.Tae Suk Oh et al conducted a study in 121 patients 
in Asan Medical center, South Korea which included the patients of 
age group 26 to 78 years and found the mean age to be 54.6 years in 
their study on Diabetic foot reconstruction using free 
flaps24.Randon et al in his study conducted at Ghant University 
hospital,Belgium found the average age to be 50 years in a case 
series of 76 patients aged between 18 to 80 years25.Kyu Kim et al in 
their study conducted in Seoul National University.Bundang 
Hospital found the average age of the patients to be 60.3 years in 
30 men and 3 women26.This is in correlation with the factor that 
most of the diabetics develop peripheral neuropathy 10 years after 
the onset of the disease leading to the maximum incidence of 
diabetic ulcers from 50 years onwards. 
Majority of the patients were males 68(87.17%) and 10 
(12.82%) were females in our study .This is in accordance with 
Randon et al study25.In Indian scenario males are mostly the bread 
winners working in fields or as laborers mostly barefoot 
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predisposing to repeated trauma in the neuropathic foot leading to 
ulcerations.   
 Majority of the patients i.e., 49(62.82%) are found to be 
smokers in our study .In the study conducted by Tae Suk Oh et al, 
34.25 were found to be smokers 24. Smoking habits are higher in 
Indian men which predisposes to the Peripheral Arterial Disease, 
moreso in diabetic patients leading to ulcerations. 
 Revascularization procedures are needed to improve the 
vascularity to the critically ischemic limb in the diabetics. In 
nonhealing ulcers failing conservative therapy revascularization 
aids in limb salvage. In our study of the 78 patients, 42(53.84%) 
had undergone angioplasty and 36(46.15%) had undergone bypass 
procedures.Revascularisation improves the limb salvage rate by 
more than 50 %( 27 – Karl A Illig). 
 In our study, majority of patients underwent 2 or more 
debridements to achieve a good wound bed and to reduce infection 
preceding the reconstructive procedure.Latency period is the time 
period between the revascularization and reconstruction.This is the 
period in which wound healing is established due to the 
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improvement in vascularity of the foot. In our study the average 
latency period is 35.36 days ranging between 20 to 60 days. 
 Negative pressure wound therapy was used in our study 
in 42(53.8%) of patients. Negative pressure wound therapy was 
found to reduce the time taken for wound closure and increase 
healing 18. 
Reconstruction of the foot after the revascularization is 
necessary as revascularization alone is not sufficient for the healing 
and to prevent limb loss. In our study, the reconstruction was 
carried out by locoregional flaps and free flaps.Microvascular free 
flap surgery is proven to be safe procedure for providing  stable 
cover to the wounds after revascularization.In our study,30 patients 
underwent locoregional flaps and 48 of them underwent free flaps 
for reconstruction.L.Scott Lewin,Duke University medical 
center,Durham have found regional flaps to be viable option in 
treating foot defects with impaired vascularity21.In our study the 
locoregional flaps done were Superiorly based Fasciocutaneous 
flaps were done in 11cases,Inferiorly based Fasciocutaneous flaps 
were done in 5 cases,Reverse Superficial Sural Artery flap in 9 
cases,Perforator flap in 5 cases.  
  69
Catherine De Blacam in her study conducted in Royal College 
of Surgeons, Dublin found a flap loss of about 3.2% with Reverse 
Superficial Sural Artery flap. They also found that distal tip 
necrosis problem in the Reverse Superficial Sural Artery flap in 
15.3%28.Brenda K. Cohen conducted a study in 33 patients with 
medial plantar artery flap and found that it provides excellent like 
tissue reconstruction of the foot providing good weight bearing 
ability.6 cases had complications in their study29. 
Free flaps used for reconstruction in our study are Free 
Latissimus Dorsi muscle flap used in 19 cases, free Gracilis muscle 
flap in 6 cases, Radial Free Forearm Flap in 12 cases,Parascapular 
free flap in 5 cases, Free Anterolateral thigh flap in 4 cases. Free 
Medial Plantar artery taken as a free flap from the opposite foot 
was used in 2 cases to give a like tissue reconstruction. H.Sunar et 
al in the study conducted in Trakya University,Turkey found that 
the free flap done after revascularization in a delayed setting had 
benefits like assessment of the patency of the grafts improving 
wound conditions and reducing the operating time30.Tay Suk Oh et 
al conducted a study of 121 cases with 90 Free Anterolateral Thigh 
Flaps and reported a complication rate of 9%24.Lukas Prantl et al 
conducted a study in University of Regensburg,Germany found that 
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the parascapular flap to be useful to cover defects in the weight 
bearing area31.M.Czerny et al University Medical 
school,Vienna,Austria  conducted study and found the Gracilis 
muscle flap to be a good option as it can be done under regional 
anaesthesia and minimal morbidity of the donor site32.In case of 
large foot defects Latissimus Dorsi Free Muscle flap is the 
preferred flap. 
In our study, complications like hematoma were seen in 2 
cases; flap necrosis is seen in Reverse Superficial Sural artery Flap. 
Partial flap necrosis is seen in 1 Antero Lateral Thigh Flap, Wound 
dehiscence in 1 perforator flap, Ulcer recurrence was found in 2 
Latissimus Dorsi Flaps. The overall complication rates was 
9%.This is similar to the study done by Tae Suk Oh et al 24. 
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CONCLUSION 
Following revascularization of the diabetic foot which is key 
to establish the vascularity in ischemic foot and helps in controlling 
the infection .Infection is also controlled by appropriate antibiotics 
and wound debridements to remove the necrotic tissues which help 
in the healing by formation of granulation tissue. Negative pressure 
wound therapy is used in the latency period to help in the faster 
healing.Microvascular free flaps bring in well vascularized tissue 
for the stable cover of the diabetic foot with minimal complications 
where there is a paucity of locally available flaps. Hand held 
Doppler is adequate for planning of the reconstructive procedures. 
Angiogram may not be needed. Adjuvant procedures form an 
important part in the reconstruction process. Prevention of 
recurrences is by proper education which is most important. Use of 
orthotic foot wear ,silicone gel insoles and proper off-loading helps 
in preventing the recurrences. 
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PROTOCOL IN THE MANAGEMENT OF DIABETIC FOOT 
AFTER REVASCULARIZATION 
 
Revascularisation 
Reconstructive team assessment 
 
Healing wound without infection        Infected non - healing wound 
With granulation tissue           Wound debridements, NPWT, Antibiotics 
Underlying structures not exposed   Exposing underlying structures  
      Improved wound status 
Skin grafting                     Flap cover                            
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A case of distal femoral block.Femoropopliteal bypass done 
 
Femoropopliteal bypass scar, well settled SSG over LD flap 
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A case of like tissue reconstruction. Underlying calcaneal 
degeneration .With good preserved arch on the opposite foot treated 
with free medial plantar artery flap from opposite foot. 
 
Charcot’s degeneration of calcaneum 
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1 ½ year follow up of well settled Medial Plantar Artery Flap from 
opposite leg 
 
 
Complex composite reconstruction. Debridement done. 3rd toe 
removed. Instability of tarsum fixed by External Fixator 
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Latissimus Dorsi Flap 
 
 
  77
 
Latissimus Dorsi flap 
 
 
A case of severe tibial disease with inflow problem.Angioplasty and 
distal bypass done 
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2 1/2 yrs late postop after Debridement and ALT flap cover 
 
Femoro popliteal disease with debridement on table. RVI after 24 
hours of revascularization 
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Presented with RVI which is evident with further debridement 
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After failure of stump in modified Pirograff amputation 
 
 
Wound treated with VAC 
 
 
Microvascular composite tissue harvest 
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Free ALT flap with pedicle and lateral cutaneous nerve for 
neurotization 
 
 
After ALT transfer(4th POD) 
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Monckebergs sclerosis pre op                          Post op 
 
 
 
1 1/2 years postop 
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Heel Defect 
 
After Reverse Superficial Sural Artery Flap after 1 yr postop 
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PROFORMA FOR CLINICAL CASE STUDIES 
NAME:                                                             PS No: 
AGE:                                                                ADM No: 
SEX:                                                                 D.O.Adm: 
ADDRESS:                                                      D.O.Surg: 
                                                                          D.O.Dis:  
Ph no: 
 
PRESENTING COMPLAINTS: 
  
HISTORY OF PRESENT ILLNESS 
 
PAST HISTORY:  
Co-morbidity: 
PERSONAL HISTORY 
Smoker/ non-smoker  
 
TREATMENT HISTORY 
 
GENERAL EXAMINATION 
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LOCAL EXAMINATION 
 
PROVISIONAL DIAGNOSIS:  
 
INVESTIGATIONS 
 
TYPE OF REVASCULARISATION 
 
NUMBER OF DEBRIDEMENTS 
 
LATENCY PERIOD 
 
ADJUVANT PROCEDURE 
 
PLAN OF MANAGEMENT 
 
OPERATION:                                       Date: 
(Photographs) 
 
FOLLOW UP: 
 
  
PATIENT’S SATISFACTION: 
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PATIENT CONSENT FORM 
Study Title: Reconstruction in Revascularised Diabetic Foot 
Study centre:  Department of Plastic Reconstructive and 
Maxillofacial Surgery, 
Madras Medical College and Government 
Hospital, Chennai – 600003 
Patient’s Name:  
Patient’s Age: 
Identification Number:  
Patients may check (   ) these boxes 
I confirm that I have understood the purpose of procedure for 
the above study. I have the opportunity to ask the questions and all 
my questions and doubts have been answered to my complete 
satisfaction.  
I understand that my participation in the study is voluntary 
and that I am free to withdraw at any time without giving reason, 
without my legal right being affected.  
I understand that sponsor of the clinical study; others working 
on the sponsor’s behalf, the ethical committee and the regulatory 
authorities will not need my permission to look at my health 
records both in respect of the current study and any further research 
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that may be conducted in relation to it, even if I withdraw from the 
study. I agree to this access; however I understand that my identity 
would not be revealed. In any information released to third parties 
or published, unless as required under the law. I agree not to 
restrict the use of any data or results that arise from this study.  
I agree to take part in the above study and to comply with the 
instruction given during the study and faithfully to cooperate with 
the study team, and to immediately inform the study staff if I suffer 
from any deterioration in my health or my well - being or any 
unexpected or unusual symptoms.   
I hereby give consent to participate in this study.  
Signature/ Thumb impression of the patient:  
…………………………………………………. 
Place:                                                              
.………………………………………………… 
Patient’s name and address:                            
.………………………………………………… 
Signature of the Investigator:                         
..………….Place………… Date………………. 
Name of the Investigator:                               
…………………………………………………. 
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INFORMATION SHEET 
We are conducting study “Reconstruction in Revascularised 
Diabetic Foot” on patients attending Plastic and Reconstructive and 
Maxillofacial Surgery Department at Government General Hospital, 
Chennai.  
The purpose of this study:  
1. To study various methods to reconstruct revascularised diabetic 
foot to provide useful shoeable and stable foot or remnant of foot 
that renders him/her ambulant. 
2. To form an evolving protocol in terms of timing of 
reconstruction and the best reconstructive flap techniques. 
3. To identify complications and pitfalls related to revascularised 
diabetic foot reconstruction and describe how to avoid them.  
The privacy of the patients in the research will be 
maintained throughout the study. In the event of any publication 
or presentation resulting from the research, no personally 
identifiable information will be shared.  
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Taking part in this study is voluntary. You are free to 
decide whether to participate in this study or withdraw at any 
time; your decision will not result in any loss of benefits to 
which you are otherwise entitled.  
The results of the special study may be intimated to you at 
the end of the study period or during the study if anything is 
found abnormal which may aid in the management or treatment.  
 
 
Signature of Investigator                                                                 
Signature of Participant 
 
MuhŒ¢á x¥òjš got« 
MuhŒ¢á jiy¥ò 
r®¡fiu nehahš ghâ¡f¥g£l fhÈš ïu¤j ehs§fŸ mWitá»¢ir¡F¥ 
ã‹d® fhš kWÓuik¥ò g‰¿a X® MŒî 
bga®  :     njâ    : 
taJ  :     cŸ nehahË v©  : 
ghš  :     MuhŒ¢á nr®¡if v© : 
ïªj MuhŒ¢áÆ‹ Étu§fS« mj‹ neh¡fK« KGikahf vd¡F 
bjËthf És¡f¥g£lJ. 
vd¡F És¡f¥g£l Éõa§fis òÇªJbfh©L eh‹ vdJ 
r«kj¤ij bjÇÉ¡»nw‹. 
eh‹ ïªj r®¡fiu nehahš ghâ¡f¥g£l fhÈš ïu¤j ehs§fŸ 
mWitá»¢ir¡F¥ ã‹d® fhš kWÓuik¥ò MuhŒ¢á jhis bg‰W¡ 
bfh©nl‹.  
ïªj MuhŒ¢áÆš ãwÇ‹ Ã®gªjÄ‹¿ v‹ brhªj ÉU¥g¤â‹ngÇš 
eh‹ g§F bgW»‹nw‹. ïªj MuhŒ¢áÆš ïUªJ eh‹ vªneuK« ã‹ 
th§fyh« v‹gijí« mjdhš vªj ghâ¥ò« V‰glhJ v‹gijí« eh‹ 
òÇªJbfh©nl‹. 
mWit á»¢ir brŒtj®F K‹ tÈ bjÇahkš ïU¡f ka¡f Cá 
KJ»š nghLtj‰F r«kj« bjÇÉ¡»nw‹.  
nk‰f©l Cá nghL«nghnjh mšyJ mWitá»¢ir brŒí«nghnjh 
VnjD« ã‹ÉisîfŸ V‰glyh« v‹gijí« kU¤Jt® _y« m¿ªJ 
bfh©nl‹.  
eh‹ v‹Dila Ra ÃidîlD« k‰W« KG Rjªâu¤JlD« ïªj 
kU¤Jt MuhŒ¢áÆš v‹id nr®¤J¡bfhŸs r«kâ¡»nw‹. 
 
 
MuhŒ¢áahs® ifbah¥g«   g§nf‰ghs® ifbah¥g« 
ehŸ  : 
ïl« : 
MuhŒ¢á jftš jhŸ 
br‹id ïuhé›fhªâ muR bghJ kU¤JtidÆš x£LW¥ò 
mWit á¡ir¥ãÇÉš r®¡fiu nehahš ghâ¡f¥g£l fhÈš ïu¤j 
ehs§fŸ mWitá»¢ir¡F¥ ã‹d® fhš kWÓuik¥ò Kiw MuhŒ¢á 
ï§F eilbgW»wJ. 
Ú§fS« ïªj MuhŒ¢áÆš g§nf‰f eh§fŸ ÉU«ò»nwh«. ïªj 
MuhŒ¢áÆš c§fSila ïu¤j«, áWÚ® k‰W« °nf‹ M»at‰iw 
áw¥ò gÇnrhjid¡F c£gL¤â mj‹ jftšfis MuhŒnth«. mjdhš 
j§fsJ nehÆ‹ MŒt¿¡ifnah mšyJ á»¢irnah ghâ¥ò V‰glhJ 
v‹gijí« bjÇÉ¤J¡bfhŸ»nwh«. 
Koîfis mšyJ fU¤Jfis btËÆL«nghnjh mšyJ 
MuhŒ¢áÆ‹ nghnjh j§fsJ bgaiunah mšyJ milahs§fisnah 
btËÆlkh£nlh« v‹gijí« bjÇÉ¤J¡ bfhŸ»nwh«. 
ïªj áw¥ò á»¢irÆ‹ Koîfis MuhŒ¢áÆ‹nghJ mšyJ 
MuhŒ¢áÆ‹ KoÉ‹ nghJ j§fS¡F m¿É¡f¥gL« v‹gijí« 
bjÇÉ¤J¡ bfhŸ»nwh«. 
ïªj MuhŒ¢áÆš g§nf‰gJ j§fSila ÉU¥g¤â‹ ngÇš jh‹ 
ïU¡»wJ. nkY« Ú§fŸ vªneuK« ïªj MuhŒ¢áÆÈUªJ ã‹th§fyh« 
v‹gijí« bjÇÉ¤J¡ bfhŸ»nwh«. 
 
 
MuhŒ¢áahs® ifbah¥g«   g§nf‰ghs® ifbah¥g« 
ehŸ  : 
ïl« : 
 
S.No Age Sex IP.No Smoking
Revas
cularisation
No.of 
debridements
Latency 
period VAC
Reconstructive 
procedures
Adjuvant 
procedures Complications Follow up
1 45 M 138109 N B 3 30 N SFC Nil Nil Y
2 48 M 54381 Y B 3 38 N SFC Nil Nil Y
3 54 M 181171 Y B 2 48 N RSSA Nil Nil Y
4 61 M 58341 Y B 3 60 N SFC Nil Nil Y
5 60 M 33942 Y B 3 54 N SFC Nil Nil Y
6 58 M 87542 Y A 2 35 Y LD Os Nil Y
7 54 M 125944 Y A 2 30 Y LD Nil UR Y
8 50 M 98634 Y A 2 34 Y IFC Nil Nil Y
9 54 M 167543 N A 3 20 N SFC Nil Nil Y
10 58 M 56743 N A 2 25 N SFC Nil Nil Y
11 54 M 987652 Y B 2 35 N RSSA Nil FN Y
12 56 M 453261 Y B 2 38 Y SFC TAL Nil Y
13 58 M 567453 Y A 2 25 Y RSSA Nil Nil Y
14 61 M 76548 Y A 2 35 Y IFC Nil Nil Y
15 64 M 89765 Y A 2 20 N RSSA Nil Nil Y
16 60 M 52987 Y B 3 36 Y SFC TAL Nil Y
17 58 M 7864211 Y B 2 21 Y LD Nil Nil Y
18 59 F 897453 N A 2 28 Y RFF Nil Nil Y
19 55 M 908745 Y A 2 22 Y LD Os Nil Y
20 56 M 564198 Y A 3 29 N SFC Nil Nil Y
21 54 M 986754 Y A 2 35 Y LD TEN Nil Y
22 57 F 390876 N B 2 40 Y RSSA Nil Nil Y
23 56 M 467523 Y B 3 45 Y LD Nil UR Y
24 58 M 980675 Y A 2 22 Y LD Nil Nil Y
25 59 M 45632 Y A 2 28 Y RSSA Nil Nil Y
26 55 M 34786 Y A 2 24 Y IFC Os Nil Y
27 56 M 56432 N A 3 45 N LD Os Nil Y
28 54 M 98765 Y B 2 28 Y RFF TEN Nil Y
29 58 M 890756 Y B 3 35 Y LD Os Nil Y
30 59 F 908765 N A 2 27 Y PF Nil Nil Y
31 52 M 456732 Y A 2 28 Y RSSA Nil Nil Y
32 48 M 456387 N A 2 35 N LD Nil Nil Y
33 50 M 89076 N A 1 26 N RFF TAL Nil Y
34 49 M 78654 N B 2 30 N RSSA Nil Nil Y
35 56 F 12564 N B 2 22 N IFC Nil H Y
36 59 M 567489 Y B 3 56 N RFF Nil Nil Y
37 52 M 908765 Y A 2 28 Y G Nil Nil Y
38 59 M 567211 Y A 2 32 Y RFF Nil Nil Y
39 48 M 432115 N A 2 40 N LD TAL Nil Y
40 54 M 907654 N B 3 56 N PF Nil Nil Y
41 59 M 34256 N A 2 31 N RSSA Nil Nil Y
42 64 M 564782 Y B 3 49 N SFC TAL Nil Y
43 53 M 432562 N B 3 58 N RFF Nil Nil Y
44 47 M 764890 N B 2 35 N FMP Os Nil Y
45 51 M 765847 N A 2 28 N PSF Nil Nil Y
46 57 F 468829 N A 2 35 N G Os Nil Y
47 61 M 806778 Y A 3 45 Y SFC Nil Nil Y
48 59 F 789934 N B 2 32 N RFF Nil Nil Y
49 62 M 68888 N B 2 42 N PF Nil Nil Y
50 54 F 466373 Y B 3 52 N LD Nil Nil Y
51 58 M 378327 Y B 2 47 N RFF Nil Nil Y
52 56 M 378838 N A 2 33 N ALT Nil PFN Y
53 55 M 838637 Y A 2 25 N RFF Nil Nil Y
54 59 F 635433 N A 2 42 N LD Nil Nil Y
55 51 M 65672 N A 2 26 N RFF Nil Nil Y
56 53 M 33889 Y A 2 32 N ALT Nil Nil Y
57 49 M 64432 Y A 2 26 N ALT Nil Nil Y
58 56 M 777666 N B 3 44 N PSF Nil Nil Y
59 51 M 543287 Y B 2 28 Y PF TEN Nil Y
60 52 M 53897 Y B 1 22 Y LD Os Nil Y
61 57 F 67545 N A 2 36 Y RFF Nil Nil Y
62 54 M 432521 Y A 2 39 Y G TAL Nil Y
63 59 M 87628 N A 2 28 Y PSF Nil Nil Y
64 61 M 423525 Y A 3 48 Y LD Os Nil Y
65 56 M 776556 Y A 2 26 Y RFF Nil Nil Y
66 52 M 89899 Y B 3 41 Y LD TAL Nil Y
67 56 M 676787 N B 2 38 Y PSF Nil H Y
68 59 M 54456 Y B 3 51 Y G Nil Nil Y
69 53 M 87654 Y B 2 42 Y LD Nil Nil Y
70 51 M 987653 Y B 3 44 Y PF Nil WD Y
71 55 F 54289 Y B 2 28 Y LD Nil Nil Y
72 56 M 88272 Y B 2 34 Y MP Nil Nil Y
73 48 M 676755 Y B 2 58 Y PSF Nil Nil Y
74 53 M 57682 Y B 3 39 Y ALT Nil Nil Y
75 56 M 44345 Y A 2 32 Y G Nil Nil Y
76 59 M 77666 Y A 2 28 Y ALT Nil Nil Y
77 54 M 45788 N A 2 34 Y G Nil Nil Y
78 57 M 987652 N A 2 36 Y LD Nil Nil Y
35
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KEY FOR MASTER CHART 
TYPE OF REVASCULARIZATION 
A – Angioplasty 
B- Bypass procedures 
Reconstruction Procedures 
SFC  - Superiorly based Fascio Cutaneous flap 
IFC  - Inferiorly based Fascio Cutaneous flap 
RSSA – Reverse Superficial Sural Artery Flap 
LD     - Latissimus Dorsi flap 
RFF - Radial Free Forearm flap 
PF  - Perforator Flap 
G  -  Gracilis muscle flap 
PSF  - Para Scapular Flap 
FMP  -Free Medial Plantar artery flap 
ALT – Antero Lateral Thigh flap 
  91
Adjuvant procedures 
Os – Ostectomy 
TAL – Tendo Achilles Lengthening 
TEN – Tenotomy 
Complications 
FN – Flap Necrosis 
PFN – Partial Flap Necrosis 
WD – Wound Dehiscence 
H – Hematoma 
UR – Ulcer Recurrence 
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